A Williams1, G Scadding. 1. Global Health Outcomes, GlaxoSmithKline, Stockley Park, UK. awilliams42@sky.com
Abstract
INTRODUCTION: Many people with rhinitis choose to self-medicate, frequently relying on pharmacy advice. We have investigated the effectiveness of such a treatment. METHODS: To obtain data regarding treatment and outcome of individuals with rhinitis who have not consulted a physician in the past 2 years, a cross-sectional survey was performed. A random sample of the French, German and United Kingdom general population (n = 15,085) was screened, resulting in 818 individuals with rhinitis. Each of these respondents was sent a postal questionnaire. RESULTS: A total of 610 (74.6%) individuals returned the questionnaire. A sum of 42% (256) respondents described their symptoms as moderate and 5% (31) as severe. Multiple triggers were reported by 442 (72.5%) and 30% of respondents reported sleep disturbance (increased to 44% in sedating antihistamine users) > or = 8 nights/month, resulting in reduced cognition and productivity loss in 14.5%. Individuals stated that they did not attend the physician because their symptoms were too trivial (378 - 63.9%) or over-the-counter (OTC) medication was adequate (341 - 57.6%). Only 217 respondents reported currently taking OTC medication (France 30; Germany 82; UK 105). In all countries, antihistamine was the main treatment taken (non-sedating in 38% and sedating in 23% of subjects). Intranasal corticosteroid use (18 - 8.3%) was mainly in the UK where it is available OTC. CONCLUSION: Individuals with rhinitis who do not consult a physician report multiple sensitization, reduced sleep and cognition. Drug utilization appears suboptimal, particularly for those reporting moderate or severe symptoms. Reliance on pharmacy or self-medication may not be adequate for some people.
INTRODUCTION: Many people with rhinitis choose to self-medicate, frequently relying on pharmacy advice. We have investigated the effectiveness of such a treatment. METHODS: To obtain data regarding treatment and outcome of individuals with rhinitis who have not consulted a physician in the past 2 years, a cross-sectional survey was performed. A random sample of the French, German and United Kingdom general population (n = 15,085) was screened, resulting in 818 individuals with rhinitis. Each of these respondents was sent a postal questionnaire. RESULTS: A total of 610 (74.6%) individuals returned the questionnaire. A sum of 42% (256) respondents described their symptoms as moderate and 5% (31) as severe. Multiple triggers were reported by 442 (72.5%) and 30% of respondents reported sleep disturbance (increased to 44% in sedating antihistamine users) > or = 8 nights/month, resulting in reduced cognition and productivity loss in 14.5%. Individuals stated that they did not attend the physician because their symptoms were too trivial (378 - 63.9%) or over-the-counter (OTC) medication was adequate (341 - 57.6%). Only 217 respondents reported currently taking OTC medication (France 30; Germany 82; UK 105). In all countries, antihistamine was the main treatment taken (non-sedating in 38% and sedating in 23% of subjects). Intranasal corticosteroid use (18 - 8.3%) was mainly in the UK where it is available OTC. CONCLUSION: Individuals with rhinitis who do not consult a physician report multiple sensitization, reduced sleep and cognition. Drug utilization appears suboptimal, particularly for those reporting moderate or severe symptoms. Reliance on pharmacy or self-medication may not be adequate for some people.
Authors: A Simon Carney; David B Price; Pete K Smith; Richard Harvey; Vicky Kritikos; Sinthia Z Bosnic-Anticevich; Louise Christian; Derek A Skinner; Victoria Carter; Alice Ms Durieux Journal: Pragmat Obs Res Date: 2017-08-30
Authors: Olga Lourenço; Biljana Cvetkovski; Vicky Kritikos; Rachel House; Sophie Scheire; Elisio M Costa; João A Fonseca; Enrica Menditto; Anna Bedbrook; Slawomir Bialek; Vitalis Briedis; Koen Boussery; G Walter Canonica; Tari Haahtela; Piotr Kuna; Joaquim Mullol; Valentina Orlando; Boleslaw Samolinski; Dana Wallace; Catherine Duggan; Ema Paulino; Gonçalo S Pinto; Lars-Åke Söderlund; Jean Bousquet; Sinthia Bosnic-Anticevich Journal: Clin Transl Allergy Date: 2022-10-05 Impact factor: 5.657
Authors: Carlo Lombardi; Eleonora Musicco; Francesco Rastrelli; Germano Bettoncelli; Giovanni Passalacqua; Giorgio Walter Canonica Journal: Asthma Res Pract Date: 2015-06-04
Authors: Raja'a A Al-Qudah; Rana Abu Farha; Maram M Al Ali; Nour S Jaradaneh; Mohamed Izham Mohamed Ibrahim Journal: J Pharm Bioallied Sci Date: 2021-05-26